Home - Products - Others - Other Targets - EGF Receptor (988-993) (phosphorylated) (human)

EGF Receptor (988-993) (phosphorylated) (human)

CAS No. ———

EGF Receptor (988-993) (phosphorylated) (human)( ——— )

Catalog No. M41078 CAS No. ———

EGF Receptor (988-993) (phosphorylated) (human)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EGF Receptor (988-993) (phosphorylated) (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    EGF Receptor (988-993) (phosphorylated) (human)
  • Description
    EGF Receptor (988-993) (phosphorylated) (human)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    804.7
  • Molecular Formula
    C31H46N7O16P
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 3-Sulfopropanoic aci...

    3-Sulfopropanoic acid, a major metabolite of treprostinil and its prodrug ALZ-801, is an endogenous molecule present in the cerebrospinal fluid (CSF) of AD patients that inhibits the formation of Aβ42 oligomers.

  • Compound K

    HIV-IN-11 is part of the hydroxylaminoglutaramide (HAPA) transition state isomeric series of HIV protease inhibitors and is a potent and selective inhibitor of HIV-1 protease. HIV-IN-11 competitively inhibits HIV-1 PR (Ki: 0.049 nM) and potently inhibits replication of HIV(IIIb)-infected MT4 lymphocytes at concentrations of 25.0-50.0 nM. HIV-IN-11 displays a longer half-life than indinavir sulfate in animal models and serves as a promising second-generation HIV protease inhibitor.

  • Allatostatin II

    Inhibitors of juvenile hormone synthesis in insects.